Constipation in children
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
no impaction: <1 year of age
dietary modification
Dietary changes remain a common initial recommendation as low fluid and fibre intake often contribute to the development of constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Fluid and fibre intake should not be increased above daily recommendations as there is no evidence to suggest that this improves constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com [41]Tabbers MM, Boluyt N, Berger MY, et al. Nonpharmacologic treatments for childhood constipation: systematic review. Pediatrics. 2011 Oct;128(4):753-61. http://www.ncbi.nlm.nih.gov/pubmed/21949142?tool=bestpractice.com
Prune or pear juice may be given to infants to increase stool water content and frequency. For infants younger than 6 months, 1-3 mL of juice per kg diluted with 30-60 mL of water may be an appropriate dose.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com
osmotic laxative
Treatment recommended for ALL patients in selected patient group
Softening the stool with osmotic agents is often needed.
Response to lactulose may take 24 to 48 hours.
Following resolution of acute constipation, children should maintain dietary improvements and osmotic laxatives (e.g., lactulose) to establish normal bowel habits. Generally, osmotic laxative maintenance therapy is recommended for at least 1 month after a good response to treatment.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com
Primary options
lactulose: 1 mL/kg orally once or twice daily
More lactulose1 mL = 0.7 g.
no impaction: ≥1 year of age
dietary and behaviour modification
Dietary changes remain a common initial recommendation as low fluid and fibre intake often contribute to the development of constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Recommended daily fluid intake is around 4 cups per day for 1 to 3 year olds, 5 cups for 4 to 8 year olds, and 7 to 8 cups for older children.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Adding 5 g to the child's age in years can be used to calculate recommended daily fibre intake.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Fluid and fibre intake should not be increased above daily recommendations as there is no evidence to suggest that this improves constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com [41]Tabbers MM, Boluyt N, Berger MY, et al. Nonpharmacologic treatments for childhood constipation: systematic review. Pediatrics. 2011 Oct;128(4):753-61. http://www.ncbi.nlm.nih.gov/pubmed/21949142?tool=bestpractice.com
Regular toilet habits and behavioural modification (unhurried time on the toilet after meals, relaxation techniques, a reward system linked with successful toilet usage, and a diary of stool frequency) are recommended.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com
The anxiety of both parent and child should be addressed. The child may be fearful of painful defecation, and parents need to understand that forcing toilet training in this situation will be ineffective. In older children, faecal incontinence and its social consequences need a non-accusatory, sympathetic management approach. It may be necessary to repeat the education several times during treatment.
Encouraging more exercise and physical activity may be appropriate in older children, as well as pelvic physiotherapy and biofeedback, which has been long used and proven in adults.[49]Zar-Kessler C, Kuo B, Cole E, et al. Benefit of pelvic floor physical therapy in pediatric patients with dyssynergic defecation constipation. Dig Dis. 2019;37(6):478-85. https://www.karger.com/Article/FullText/500121 http://www.ncbi.nlm.nih.gov/pubmed/31096249?tool=bestpractice.com
osmotic laxative or faecal softener
Treatment recommended for ALL patients in selected patient group
Softening the stool with osmotic agents is often needed. Response to lactulose may take 24 to 48 hours, while response to polyethylene glycol (PEG) usually takes 1 to 2 hours.
There is evidence that PEG is more effective than lactulose in the treatment of chronic constipation in terms of stool frequency per week, form of stool, and relief of abdominal pain.[42]Gordon M, MacDonald JK, Parker CE, et al. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2016;(8):CD009118. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009118.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/27531591?tool=bestpractice.com [43]Lee-Robichaud H, Thomas K, Morgan J, et al. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007570. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007570.pub2/full http://www.ncbi.nlm.nih.gov/pubmed/20614462?tool=bestpractice.com [44]Zurad EG, Johanson JF. Over-the-counter laxative polyethylene glycol 3350: an evidence-based appraisal. Curr Med Res Opin. 2011 Jul;27(7):1439-52. http://www.ncbi.nlm.nih.gov/pubmed/21604961?tool=bestpractice.com [45]Wang Y, Wang B, Jiang X, et al. Polyethylene glycol 4000 treatment for children with constipation: a randomized comparative multicenter study. Exp Ther Med. 2012 May;3(5):853-6. https://www.spandidos-publications.com/10.3892/etm.2012.491 http://www.ncbi.nlm.nih.gov/pubmed/22969980?tool=bestpractice.com PEG has also been shown to be superior to other osmotic agents with regard to taste and patient acceptance.[46]Gomes PB, Duarte MA, Melo Mdo C. Comparison of the effectiveness of polyethylene glycol 4000 without electrolytes and magnesium hydroxide in the treatment of chronic functional constipation in children. J Pediatr (Rio J). 2011 Jan-Feb;87(1):24-8. http://www.ncbi.nlm.nih.gov/pubmed/21116598?tool=bestpractice.com
Following resolution of acute constipation, children should maintain dietary improvements, behavioural modification (unhurried time on the toilet after meals, a reward system linked with successful toilet usage, and a diary of stool frequency) and osmotic laxatives (e.g., lactulose, PEG 3350 electrolyte solutions) or stool softeners (e.g., docusate sodium or mineral oil [suitable for children ≥5 years old]) to establish normal bowel habits. Generally, osmotic laxative maintenance therapy is recommended for at least 1 month after a good response to treatment.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com PEG appears to be a safe medication; however, there have been no long-term studies completed in children.[46]Gomes PB, Duarte MA, Melo Mdo C. Comparison of the effectiveness of polyethylene glycol 4000 without electrolytes and magnesium hydroxide in the treatment of chronic functional constipation in children. J Pediatr (Rio J). 2011 Jan-Feb;87(1):24-8. http://www.ncbi.nlm.nih.gov/pubmed/21116598?tool=bestpractice.com
Primary options
polyethylene glycol/electrolytes: consult product literature for guidance on dosage
OR
lactulose: 1 mL/kg orally once or twice daily
More lactulose1 mL = 0.7 g.
OR
docusate sodium: children <3 years of age: 10-40 mg/day orally given in 1-4 divided doses; children 3-6 years of age: 20-60 mg/day orally given in 1-4 divided doses; children >6 years of age: 40-150 mg/day orally given in 1-4 divided doses
OR
liquid paraffin: children 5-11 years of age: 5-15 mL orally once daily when required; children >12 years of age: 15-45 mL orally once daily when required
stimulant laxative
Additional treatment recommended for SOME patients in selected patient group
Some children may require the addition of a short-term stimulant laxative (e.g., senna) to achieve regular bowel movements.
Primary options
senna: children 2-6 years of age: 0.5 to 1 tablet orally once daily when required; children 6-12 years of age: 1-2 tablets orally once daily when required
More sennaOne tablet = 7.5 mg sennosides.
faecal softener or stimulant laxative
Treatment recommended for ALL patients in selected patient group
Withholding behaviour is an active behaviour resulting from a contraction of pelvic floor muscles that reduces the likelihood of defecation. Usually affects children between 1 and 5 years old.
These children may require the addition of a stool softener (e.g., polyethylene glycol) or short-term stimulant laxative (e.g., senna) to achieve regular bowel movements.
Primary options
polyethylene glycol/electrolytes: consult product literature for guidance on dosage
OR
senna: children 2-6 years of age: 0.5 to 1 tablet orally once daily when required
More sennaOne tablet = 7.5 mg sennosides.
with impaction: <1 year of age
osmotic laxative
Faecal impaction is the retention of faeces, usually palpable per abdomen, to a degree where spontaneous evacuation is unlikely.[40]Clayden GS, Keshtgar AS, Carcani-Rathwell I, et al. The management of chronic constipation and related faecal incontinence in childhood. Arch Dis Child Ed Pract. 2005;90:ep58-67. http://ep.bmj.com/content/90/3/ep58.full
These children may require an osmotic laxative (e.g., lactulose) to achieve regular bowel movements.
Response to lactulose may take 24 to 48 hours.
Primary options
lactulose: 1 mL/kg orally once or twice daily
More lactulose1 mL = 0.7 g.
dietary modification
Treatment recommended for ALL patients in selected patient group
Dietary changes remain a common initial recommendation as low fluid and fibre intake often contribute to the development of constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Fluid and fibre intake should not be increased above daily recommendations as there is no evidence to suggest that this improves constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com [41]Tabbers MM, Boluyt N, Berger MY, et al. Nonpharmacologic treatments for childhood constipation: systematic review. Pediatrics. 2011 Oct;128(4):753-61. http://www.ncbi.nlm.nih.gov/pubmed/21949142?tool=bestpractice.com
Following resolution of acute constipation, children should maintain dietary improvements and osmotic laxatives (e.g., lactulose) to establish normal bowel habits. Generally, it is necessary to maintain medication until the child has achieved regular bowel movements without difficulty.
with impaction: 1 to 3 years of age
osmotic laxative
Faecal impaction is the retention of faeces, usually palpable per abdomen, to a degree where spontaneous evacuation is unlikely.[40]Clayden GS, Keshtgar AS, Carcani-Rathwell I, et al. The management of chronic constipation and related faecal incontinence in childhood. Arch Dis Child Ed Pract. 2005;90:ep58-67. http://ep.bmj.com/content/90/3/ep58.full
These children may require an osmotic laxative to achieve regular bowel movements.
Osmotic laxatives, such as polyethylene glycol (PEG) 3350 electrolyte solutions, have been shown to be effective.[48]Candy DC, Edwards D, Geraint M. Treatment of faecal impaction with polyethylene glycol plus electrolytes (PEG + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy. J Pediatr Gastroenterol Nutr. 2006 Jul;43(1):65-70. http://www.ncbi.nlm.nih.gov/pubmed/16819379?tool=bestpractice.com
Other oral medications for initial disimpaction include lactulose and glycerol. PEG appears to be a safe medication; however, there have been no long-term studies completed in children. There is consistent evidence that PEG is superior to lactulose with regard to rates of clinical remission, improvement in symptoms, and patient tolerance.[43]Lee-Robichaud H, Thomas K, Morgan J, et al. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007570. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007570.pub2/full http://www.ncbi.nlm.nih.gov/pubmed/20614462?tool=bestpractice.com [44]Zurad EG, Johanson JF. Over-the-counter laxative polyethylene glycol 3350: an evidence-based appraisal. Curr Med Res Opin. 2011 Jul;27(7):1439-52. http://www.ncbi.nlm.nih.gov/pubmed/21604961?tool=bestpractice.com [45]Wang Y, Wang B, Jiang X, et al. Polyethylene glycol 4000 treatment for children with constipation: a randomized comparative multicenter study. Exp Ther Med. 2012 May;3(5):853-6. https://www.spandidos-publications.com/10.3892/etm.2012.491 http://www.ncbi.nlm.nih.gov/pubmed/22969980?tool=bestpractice.com [46]Gomes PB, Duarte MA, Melo Mdo C. Comparison of the effectiveness of polyethylene glycol 4000 without electrolytes and magnesium hydroxide in the treatment of chronic functional constipation in children. J Pediatr (Rio J). 2011 Jan-Feb;87(1):24-8. http://www.ncbi.nlm.nih.gov/pubmed/21116598?tool=bestpractice.com
All treatments are likely to increase the degree of faecal incontinence at first as the stools are loosened.
Softer stools are more difficult for children to withhold, and so their behaviour may deteriorate during the period of disimpaction if they are actively withholding.
Primary options
polyethylene glycol/electrolytes: consult product literature for guidance on dosage
OR
lactulose: 1 mL/kg orally once or twice daily
More lactulose1 mL = 0.7 g.
OR
glycerol rectal: 1 infant suppository inserted into rectum once or twice daily when required
dietary and behaviour modification
Treatment recommended for ALL patients in selected patient group
Dietary changes remain a common initial recommendation as low fluid and fibre intake often contribute to the development of constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Recommended daily fluid intake is around 4 cups per day for 1 to 3 year olds.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Adding 5 g to the child's age in years can be used to calculate recommended daily fibre intake.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Fluid and fibre intake should not be increased above daily recommendations as there is no evidence to suggest that this improves constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com [41]Tabbers MM, Boluyt N, Berger MY, et al. Nonpharmacologic treatments for childhood constipation: systematic review. Pediatrics. 2011 Oct;128(4):753-61. http://www.ncbi.nlm.nih.gov/pubmed/21949142?tool=bestpractice.com Regular toilet habits and behavioural modification (unhurried time on the toilet after meals, a reward system linked with successful toilet usage, and a diary of stool frequency) are recommended.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com
The anxiety of both parent and child should be addressed. The child may be fearful of painful defecation, and parents need to understand that forcing toilet training in this situation will be ineffective.
faecal softener
Additional treatment recommended for SOME patients in selected patient group
In addition to maintaining dietary improvements, behavioural modification (unhurried time on the toilet after meals, a reward system linked with successful toilet usage, and a diary of stool frequency), and osmotic laxatives (e.g., lactulose, polyethylene glycol 3350 electrolyte solutions) following resolution of acute impaction, these children may require the addition of a faecal softener (e.g., docusate sodium) to establish normal bowel habits. Generally, it is necessary to maintain medication until the child has achieved regular bowel movements without difficulty.
Primary options
docusate sodium: children <3 years of age: 10-40 mg/day orally given in 1-4 divided doses; children 3-6 years of age: 20-60 mg/day orally given in 1-4 divided doses
with impaction: ≥4 years of age
osmotic laxative
Faecal impaction is the retention of faeces, usually palpable per abdomen, to a degree where spontaneous evacuation is unlikely.[40]Clayden GS, Keshtgar AS, Carcani-Rathwell I, et al. The management of chronic constipation and related faecal incontinence in childhood. Arch Dis Child Ed Pract. 2005;90:ep58-67. http://ep.bmj.com/content/90/3/ep58.full
These children may require an osmotic laxative to achieve regular bowel movements.
Osmotic laxatives, such as polyethylene glycol (PEG) 3350 electrolyte solutions, have been shown to be effective.[48]Candy DC, Edwards D, Geraint M. Treatment of faecal impaction with polyethylene glycol plus electrolytes (PEG + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy. J Pediatr Gastroenterol Nutr. 2006 Jul;43(1):65-70. http://www.ncbi.nlm.nih.gov/pubmed/16819379?tool=bestpractice.com
Other oral medications for initial disimpaction include lactulose, glycerol, and magnesium salts such as magnesium citrate. PEG appears to be a safe medication; however, there have been no long-term studies completed in children. There is consistent evidence that PEG is superior to lactulose with regard to rates of clinical remission, improvement in symptoms, and patient tolerance.[43]Lee-Robichaud H, Thomas K, Morgan J, et al. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007570. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007570.pub2/full http://www.ncbi.nlm.nih.gov/pubmed/20614462?tool=bestpractice.com [44]Zurad EG, Johanson JF. Over-the-counter laxative polyethylene glycol 3350: an evidence-based appraisal. Curr Med Res Opin. 2011 Jul;27(7):1439-52. http://www.ncbi.nlm.nih.gov/pubmed/21604961?tool=bestpractice.com [45]Wang Y, Wang B, Jiang X, et al. Polyethylene glycol 4000 treatment for children with constipation: a randomized comparative multicenter study. Exp Ther Med. 2012 May;3(5):853-6. https://www.spandidos-publications.com/10.3892/etm.2012.491 http://www.ncbi.nlm.nih.gov/pubmed/22969980?tool=bestpractice.com [46]Gomes PB, Duarte MA, Melo Mdo C. Comparison of the effectiveness of polyethylene glycol 4000 without electrolytes and magnesium hydroxide in the treatment of chronic functional constipation in children. J Pediatr (Rio J). 2011 Jan-Feb;87(1):24-8. http://www.ncbi.nlm.nih.gov/pubmed/21116598?tool=bestpractice.com
All treatments are likely to increase the degree of faecal incontinence at first as the stools are loosened.
Softer stools are more difficult for children to withhold, and so their behaviour may deteriorate during the period of disimpaction if they are actively withholding.
Primary options
polyethylene glycol/electrolytes: consult product literature for guidance on dosage
OR
lactulose: 1 mL/kg orally once or twice daily
More lactulose1 mL=0.7 g.
OR
glycerol rectal: 1 infant suppository inserted into rectum once or twice daily when required
OR
magnesium citrate: children 4-5 years of age: 60-120 mL orally as a single dose (or in divided doses); children 6-12 years of age: 100-150 mL orally as a single dose (or in divided doses); children ≥12 years of age: 150-300 mL orally as a single dose (or in divided doses)
dietary and behaviour modification
Treatment recommended for ALL patients in selected patient group
Dietary changes remain a common initial recommendation as low fluid and fibre intake often contribute to the development of constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Recommended daily fluid intake is around 5 cups for 4 to 8 year olds and 7 to 8 cups for older children.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Adding 5 g to the child's age in years can be used to calculate recommended daily fibre intake.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com Fluid and fibre intake should not be increased above daily recommendations as there is no evidence to suggest that this improves constipation.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com [41]Tabbers MM, Boluyt N, Berger MY, et al. Nonpharmacologic treatments for childhood constipation: systematic review. Pediatrics. 2011 Oct;128(4):753-61. http://www.ncbi.nlm.nih.gov/pubmed/21949142?tool=bestpractice.com
Regular toilet habits and behavioural modification (unhurried time on the toilet after meals, a reward system linked with successful toilet usage, and a diary of stool frequency) are recommended.[15]Mulhem E, Khondoker F, Kandiah S. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022 May 1;105(5):469-78. http://www.ncbi.nlm.nih.gov/pubmed/35559625?tool=bestpractice.com
The anxiety of both parent and child should be addressed. The child may be fearful of painful defecation, and parents need to understand that forcing toilet training in this situation will be ineffective. In older children, faecal incontinence and its social consequences need a non-accusatory, sympathetic management approach. It may be necessary to repeat the education several times during treatment.
Encouraging more exercise and physical activity may be appropriate in older children, as well as pelvic physiotherapy and biofeedback, which has been long used and proven in adults.[49]Zar-Kessler C, Kuo B, Cole E, et al. Benefit of pelvic floor physical therapy in pediatric patients with dyssynergic defecation constipation. Dig Dis. 2019;37(6):478-85. https://www.karger.com/Article/FullText/500121 http://www.ncbi.nlm.nih.gov/pubmed/31096249?tool=bestpractice.com
stimulant laxative
Additional treatment recommended for SOME patients in selected patient group
These children may require the addition of short-term stimulant laxatives (e.g., senna, particularly for children ≤12 years of age, or bisacodyl for children >12 years of age) to achieve regular bowel movements.
Primary options
senna: children 2-6 years of age: 0.5 to 1 tablet orally once daily when required; children 6-12 years of age: 1-2 tablets orally once daily when required; children >12 years of age: 1-2 tablets orally twice daily
More sennaOne tablet = 7.5 mg sennosides.
OR
bisacodyl: children >12 years of age: 10-15 mg orally once daily at night
OR
bisacodyl rectal: children >12 years of age: 10 mg once daily at night or when required
phosphate enema
Additional treatment recommended for SOME patients in selected patient group
Older children may require a phosphate enema to clear the impacted rectum. This should be used only as a rescue measure.
The invasiveness and trauma of enemas may exacerbate the child's fear and intensify the psychological disturbance.
Avoid in children <2 years of age.
Primary options
sodium phosphate: refer to product literature for guidance on dosage
faecal softener
Additional treatment recommended for SOME patients in selected patient group
In addition to maintaining dietary improvements, behavioural modification (unhurried time on the toilet after meals, a reward system linked with successful toilet usage, and a diary of stool frequency) and osmotic laxatives (e.g., lactulose, polyethylene glycol 3350 electrolyte solutions) following resolution of acute impaction, these children may require the addition of a faecal softener (e.g., docusate sodium or mineral oil [also known as liquid paraffin, and suitable for children ≥5 years old]) to establish normal bowel habits. Generally, it is necessary to maintain medication until the child has achieved regular bowel movements without difficulty.
Primary options
docusate sodium: children 3-6 years of age: 20-60 mg/day orally given in 1-4 divided doses; children >6 years of age: 40-150 mg/day orally given in 1-4 divided doses
OR
liquid paraffin: children 5-11 years of age: 5-15 mL orally once daily when required; children >12 years of age: 15-45 mL orally once daily when required
procedural intervention
Children with longstanding constipation unresponsive to maximal medical management may be considered for procedural intervention. Procedural options include surgery via the Malone appendicostomy; or surgical, endoscopic, or radiological placement of a caecostomy tube. These procedures allow the administration of antegrade cleansing solutions directly to the colon promoting regular evacuation of stool.[50]Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):258-74. http://www.ncbi.nlm.nih.gov/pubmed/24345831?tool=bestpractice.com The use of antegrade continence enemas can be effective in improving incontinence. Evidence also supports an improvement in quality of life after such interventions.[51]Church JT, Simha S, Wild LC, et al. Antegrade continence enemas improve quality of life in patients with medically-refractory encopresis. J Pediatr Surg. 2017 May;52(5):778-82. http://www.ncbi.nlm.nih.gov/pubmed/28190558?tool=bestpractice.com Large-volume rectal irrigations using the Peristeen® device (which involves a balloon inflated in the rectum to generate pressure and hold the enema in the colon) have shown similar results to those achieved using anterograde enemas.[52]Caruso AM, Milazzo MPM, Bommarito D, et al. Advanced management protocol of transanal irrigation in order to improve the outcome of pediatric patients with fecal incontinence. Children (Basel). 2021 Dec 11;8(12):1174. https://www.mdpi.com/2227-9067/8/12/1174 http://www.ncbi.nlm.nih.gov/pubmed/34943370?tool=bestpractice.com
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer